These data are contrary to the studies performed for the HCC patients, which showed that T cells from cancer patients persistently exhibited high levels of BTLA CD4+ but not CD8+ T cells compared to HD (8). The gene discussed is CD8A; the disease is hepatocellular carcinoma.